Recordati’s Post

In recent years, biotech companies have headed to distant shorts to complete their work and research, but the United States is taking action to bring these companies back. However, pharmaceutical manufacturing companies need to consider a number of factors in order to return to U.S. soil. Balancing risk management with cost control is a must. Keep reading: #biotech #lifesciences

Knut Sturmhoefel and Ameriga Fanigliulo are out to prove to the world that alliance managers are more than just "glorified project managers" during the second day of the #ASAPEUSummit—alliance managers can "connect the dots" from their "helicopter view" in a way no one else in the organization can. https://lnkd.in/gntr3kdd  Plus, how to beat your competition to key partners, tech alliance team and business models, alliance performance management, how to manage knowledge creation in an R&D alliance, and more! #alliancemanagement #alliances #strategicalliances #alliancemanagers #collaboration #strategicpartnerships #organizationstrategy #tech #hitech #ITindustry #pharmaceutical #pharmaceuticalindustry #biopharma #biotech #biotechnology #biotechindustry

Knut Sturmhoefel and Ameriga Fanigliulo are out to prove to the world that alliance managers are more than just "glorified project managers" during the second day of the #ASAPEUSummit—alliance managers can "connect the dots" from their "helicopter view" in a way no one else in the organization can. https://lnkd.in/g4uxusbt  Plus, how to beat your competition to key partners, tech alliance team and business models, alliance performance management, how to manage knowledge creation in an R&D alliance, and more! #alliancemanagement #alliances #strategicalliances #alliancemanagers #collaboration #strategicpartnerships #organizationstrategy #tech #hitech #ITindustry #pharmaceutical #pharmaceuticalindustry #biopharma #biotech #biotechnology #biotechindustry

I post occasionally about #strategicalliance process, best practices etc - sharing this for anyone involved or interested, just a few of the many topics you will find at ASAP - education, certification, engagement with leading practitioners & more. If you’re involved in alliances, this is a vital resource, check it out!

🚀 Get ready for a journey into the heart of innovation and growth! Introducing our new video about how we are building the future of Active Pharmaceutical Ingredients manufacturing. With 70 million euros of investment per year, we have outlined an ambitious development plan to turn our vision into reality. You can learn about the projects we are implementing, focused on growth, innovation and sustainability. We are excited to share this journey with you! 🌱💼 #Growth #Investment #Sustainability #FIS #Innovation

Happy Friday All! As we head into the weekend, here is another Industry News Weekly Wrap-Up highlighting advancements and challenges within the healthcare industry: 1️⃣ Biotechnology's role in creating sustainable pharmaceutical solutions. 2️⃣ The growing threat of counterfeit weight-loss medications. 3️⃣ Innovations emerging from the Boston biotech sector. Impact on the industry: ➜ Increased focus on sustainability and eco-friendly practices. ➜ Heightened regulatory vigilance against counterfeit drugs. ➜ Continued investment in biotech innovations, driving sector growth. #SustainablePharma #BiotechInnovation #HealthcareTrends2024 #CounterfeitMedicineAwareness #BostonBiotech Read these stories and more! 👇

We surveyed more than 100 #pharma leaders to learn how their supply chain and manufacturing teams are approaching digital transformation. We discovered three key actions pharma companies can take to digitally transform their supply chains: https://bit.ly/3YhohEm #pharmasupplychain #lifesciences

There is solid evidence that innovative treatments have drastically improved our lives. We live longer and we enjoy better quality of life. But.. …do we do enough to protect access to innovative treatments? Have we developed a business environment that is sustainable and predictable? Have we looked at best practices from other EU member states? PhARMA Innovation Forum Greece (PIF) has clearly articulated that more needs to be done. The time to act is now. The time to seek synergies is now. Let’s not waste another opportunity!

🔓 Breaking Down Barriers to Entry: Navigating Pharma's Challenges Entering the pharmaceutical market isn't just about innovation; it's about overcoming barriers that often obstruct new entrants. 🛑 Challenges abound, from stringent regulations to market saturation. However, innovation holds the key. Exploring novel solutions can pave the way for a smoother entry. 🧩 Let's dissect these hurdles together. How can strategic thinking and innovative approaches dismantle these barriers? Share your insights in the comments below! #MarketInsights #PharmaStrategy #InnovationIsKey

For emerging #biopharma companies, making the transition from an R&D-focused organization to one with commercial capabilities can bring major change. In this short video, Joe Magliocco talks about the final 2 "make or break" factors for emerging #pharmaceutical and #biotech companies. Read more here https://lnkd.in/gW6wDC2F